Evidence map›Paper›PMID 41280807›Full record

ReviewACS omega2025

A Comprehensive Review of Medicarpin: A Phytoalexin with Therapeutic Potential.

Matheus Hikaru Tanimoto, Aline Mayrink de Miranda, Jennyfer Andrea Aldana-Mejía, Luciana Silva de Araújo, Ana Maria de Freitas Pinheiro, Ana Fernanda Guimarães Trindade, Júlia Mina Fernandes, Samir A Ross, Jairo Kenupp Bastos

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matheus Hikaru TanimotoSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14040-903, Brazil.
Aline Mayrink de MirandaFaculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP 05508-000, Brazil.
Jennyfer Andrea Aldana-MejíaNational Center for Natural Products Research, School of Pharmacy, The University of Mississippi, Oxford, Mississippi 38677, United States.ORCID https://orcid.org/0000-0003-0736-1899
Luciana Silva de AraújoSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14040-903, Brazil.
Ana Maria de Freitas PinheiroSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14040-903, Brazil.ORCID https://orcid.org/0000-0001-9063-2340
Ana Fernanda Guimarães TrindadeSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14040-903, Brazil.
Júlia Mina FernandesSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14040-903, Brazil.
Samir A RossNational Center for Natural Products Research, School of Pharmacy, The University of Mississippi, Oxford, Mississippi 38677, United States.ORCID https://orcid.org/0000-0002-3807-1299
Jairo Kenupp BastosSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP 14040-903, Brazil.ORCID https://orcid.org/0000-0001-8641-9686

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Initially, research on medicarpin focused on its role in crop protection, including gene modifications, allelopathic effects, antifungal potential, and biosynthetic mechanisms. Later, various biological activities were demonstrated through

Identifiers

PMID41280807
PMCPMC12631411

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.